Skip to Content

93 7530 (Metformin Hydrochloride and Rosiglitazone Maleate 500 mg / 1 mg)

Pill with imprint 93 7530 is Yellow, Elliptical / Oval and has been identified as Metformin Hydrochloride and Rosiglitazone Maleate 500 mg / 1 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Metformin/rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/rosiglitazone 500 mg / 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7530

Metformin Hydrochloride and Rosiglitazone Maleate

Imprint
93 7530
Strength
500 mg / 1 mg
Color
Yellow
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.